SCLC Subtypes and Biomarkers of the Transformative Immunotherapy Responses

J Thorac Oncol. 2023 Sep;18(9):1114-1117. doi: 10.1016/j.jtho.2023.06.009.

Authors

Brett A Schroeder¹, Anish Thomas²

Affiliations

¹ Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
² Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: [email protected].

PMID: 37599042
DOI: 10.1016/j.jtho.2023.06.009

No abstract available

Publication types

Editorial
Comment

MeSH terms

Biomarkers
Humans
Lung Neoplasms* / drug therapy

Substances

Biomarkers